NCT00188812View on ClinicalTrials.gov

Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

May 31, 2004

Study Completion Date

August 31, 2005

Conditions
Dementia Associated With Cerebrovascular Disease
Interventions
DRUG

donepezil hcl

Trial Locations (1)

M5T 2S8

Toronto Western Hopital, Toronto

All Listed Sponsors
collaborator

Eisai Inc.

INDUSTRY

lead

University Health Network, Toronto

OTHER

NCT00188812 - Safety of Donepezil in Patients With Dementia Associated With Cerebrovascular Disease | Biotech Hunter | Biotech Hunter